ClaimsFiler alerts PROCEPT investors to Sept. 22 lead-plaintiff deadline

Atlas Watchline newsroom image for: ClaimsFiler alerts PROCEPT investors to Sept. 22 lead-plaintiff deadline

ClaimsFiler says investors who bought PROCEPT BioRobotics shares between Feb. 28, 2024, and Feb. 25, 2026, have until Sept. 22, 2026, to seek lead-plaintiff status in a securities class action.

ClaimsFiler sent a shareholder alert on Aug. 21 about a securities class action against PROCEPT BioRobotics Corp., saying investors who bought shares between Feb. 28, 2024, and Feb. 25, 2026, have until Sept. 22, 2026, to apply for lead-plaintiff status.

ClaimsFiler said the case is pending in U.S. District Court for the Northern District of California under case number 26-cv-07691.

According to the notice, the case is captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation. ClaimsFiler said the action concerns alleged failures by PROCEPT and certain executives to disclose material information during the class period.

The alert says the allegations include claims that U.S. handpiece sales exceeded procedures in every quarter since the first fiscal quarter of 2023, that the company accumulated more than 10,000 handpiece units of cumulative excess field inventory, and that this mismatch would lead to a sequential decline in U.S. handpiece unit sales and missed annual revenue guidance.

ClaimsFiler also said statements about the company’s business, operations and prospects were allegedly false or lacked a reasonable basis. The notice did not include a response from PROCEPT BioRobotics.

ClaimsFiler said investors can visit its website or call a toll-free number for more information. The alert also said lawyers at Kahn Swick & Foti, LLC are available to discuss legal options.

The Sept. 22 deadline is the next date cited in the notice.

Sources

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

View the Web StoryA visual, tap-through version of this report

Share

This is the AMP version of the article. Read the full article on Atlas Watchline.